Literature DB >> 2101260

Development and outlook for a caries vaccine.

S M Michalek1, N K Childers.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2101260     DOI: 10.1177/10454411900010010401

Source DB:  PubMed          Journal:  Crit Rev Oral Biol Med        ISSN: 1045-4411


× No keyword cloud information.
  23 in total

1.  Antigenicity of a synthetic peptide from glucosyltransferases of Streptococcus mutans in humans.

Authors:  J S Chia; S W Lin; C S Yang; J Y Chen
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses.

Authors:  N K Childers; G Tong; S Mitchell; K Kirk; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

3.  No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice.

Authors:  H Marcotte; M C Lavoie
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

5.  Immunological cross-reactivity between Streptococcus mutans and human heart tissue examined by cross-immunization experiments.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

6.  Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.

Authors:  C Jespersgaard; P Zhang; G Hajishengallis; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Inhibition of glucosyltransferase activities of Streptococcus mutans by a monoclonal antibody to a subsequence peptide.

Authors:  J S Chia; R H Lin; S W Lin; J Y Chen; C S Yang
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin.

Authors:  G Hajishengallis; S M Michalek; M W Russell
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

9.  Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.

Authors:  Nikki R Rhodin; Marloes L J A Van Tilburg; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  A monoclonal antibody specific to glucosyltransferase B of Streptococcus mutans GS-5 and its glucosyltransferase inhibitory efficiency.

Authors:  Mi-Ah Kim; Min-Jeong Lee; Hae-Kyoung Jeong; Hee-Jeong Song; Hye-Jin Jeon; Kyung-Yeol Lee; Jae-Gon Kim
Journal:  Hybridoma (Larchmt)       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.